Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Predictive and prognostic factors for immunotherapy response in head and neck squamous cell carcinoma: a narrative review.

Expert review of clinical pharmacology - 1 May 2026

Calabrò Concetta, De Palma Giuseppe, Gheit Tarik, Iacovelli Serena, Mastrandrea Giovanni, Rizzo Alessandro, Palermo Loredana

Abstract excerpt

INTRODUCTION: Immune checkpoint inhibitors (ICIs) have reshaped the therapeutic landscape of head and neck squamous cell carcinoma (HNSCC). However, only a subset of patients derives durable benefit, highlighting the need for reliable predictive factors of response. AREAS COVERED: A literature search was conducted in PubMed/MEDLINE, Scopus, and Web of Science (2015-2026) using relevant keywords. This narrative...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Immune Checkpoint Inhibitors

Share to Immunotherapy

Share to Prognosis

Share to Squamous Cell Carcinoma of Head and Neck

Share to Tumor Microenvironment

Source

Identifiers

PMID: 42036954
DOI: 10.1080/17512433.2026.2665455

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Predictive and prognostic factors for immunotherapy response in head and neck squamous cell carcinoma: a narrative review.PMID 42036954Read ↗

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.Semantic proximity Read ↗

Integrating Immune Multi-Omics and Machine Learning to Improve Prognosis, Immune Landscape, and Sensitivity to First- and Second-Line Treatments for Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.Semantic proximity Read ↗

Identification of Immune-related lncRNA Panel for Predicting Immune Checkpoint Blockade and Prognosis in Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis.Semantic proximity Read ↗

Clinical, genomic and immune microenvironmental determinants of nivolumab response in head and neck squamous cell carcinoma.Semantic proximity Read ↗

Integrated Histopathology–Transcriptomic Biomarker Enhances Survival Prediction in HNSCC Patients Treated with ImmunotherapySemantic proximity Read ↗

A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

High-Sensitivity PD-L1 Staining Using Clone 73-10 Antibody and Spatial Transcriptomics for Precise Expression Analysis in Non-Tumorous, Intraepithelial neoplasia, and Squamous Cell Carcinoma of Head and NeckSemantic proximity Read ↗

An Immune-Related Gene Signature Can Predict Clinical Outcomes and Immunotherapeutic Response in Oral Squamous Cell CarcinomaSemantic proximity Read ↗

An Immune-associated lncRNA Signature Predicts the Survival of Patients With Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.